|
Laxman Pai, Opalesque Asia: Venture capital (VC) investment in Asia remained quite strong in Q4'21 with $46.2bn raised across 2,440 deals, helping lift total VC investment to a new record high.
According to a report by KPMG, several companies across the Asia Pacific region attracted large deals, including Indonesia-based J&T Express ($2.5 billion), and China-based companies - Regor Therapeutics ($1.5 billion), GTA Semiconductor ($1.25 billion), and Nanjing LingHang Technology ($1.2 billion), Singapore-based MoonPay ($555 million), and India-based PharmEasy ($350 million).
VC investment in China remained solid in Q4'21, propelled by several large deals involving AI-driven companies, including Nanjing LingHang Technology ($1.2 billion), Dreame Technology ($558 million), and Avatar Technology ($377 million). The quarter also saw AI company SenseTime raise $740 million in its debut on the HKSE.
VC investment in India dropped dramatically in Q4'21 compared to the record high set in Q3'21, said the report. Despite the optics, however, Q4'21 was India's second-best quarter of VC investment ever. A growing economy, stable government policies, and a growing middle class have all contributed to the upswell in interest from VC investors.
Meanwhile, corporate VC activity was very strong in Asia in 2021, with the number of CVC deals reaching a record high and CVC investment falling just shy of one. India, in particular, saw a steep rise in both the number of CVC deals ...................... To view our full article Click here
|
RSS
